Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA)
Clinical trial NCT03881059 · COMPLETED
Trial details
- NCT number
- NCT03881059
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-01
- Primary completion
- 2020-04-27
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.